Biosimilar firms urge government action to boost sluggish market
This article was originally published in Scrip
Executive Summary
A feeling that biosimilars have still not delivered on their promise despite their years on the market pervaded this year’s annual biosimilars conference held by the European Generic medicines Association (EGA) at the Tower Hotel in London’s docklands.